Quick Answer
Three unrelated mechanisms sit behind the compounds usually grouped as skin peptides. Copper complexes such as GHK-Cu and AHK-Cu carry a metal ion and are studied in the context of matrix remodelling and gene expression. Signal peptides such as Matrixyl are short matrix derived sequences, usually palmitoylated to aid penetration, studied as feedback signals to collagen producing cells. Neuropeptide analogues such as SNAP-8 are modelled on proteins involved in vesicle fusion at the neuromuscular junction. Reading a claim about one and applying it to another is the most common error in this area.
| Class | Examples | Proposed mechanism | Evidence base |
|---|---|---|---|
| Copper complexes | GHK-Cu, AHK-Cu | Copper delivery, matrix remodelling, gene expression | Broadest of the three, mostly in vitro and animal |
| Matrix signal peptides | Matrixyl (palmitoyl pentapeptide-4) | Collagen fragment mimicry signalling repair to fibroblasts | Moderate, formulation and penetration focused |
| Neuropeptide analogues | SNAP-8 | Competitive interference with SNARE complex assembly | Narrowest, mechanistic and analogy driven |
Cosmetic and dermatological peptides are sold as a single category and discussed as if they were a single mechanism. They are not. The compounds most often named together, GHK-Cu, AHK-Cu, Matrixyl and SNAP-8, are studied under three separate mechanistic models with almost nothing in common beyond being short amino acid chains. This article separates them, because the separation determines which claims in the literature transfer between compounds and which do not.
Class one: copper binding complexes
GHK is a tripeptide, glycine, histidine and lysine, first isolated from human plasma in the 1970s. Its defining property is a high affinity for copper (II). The complex it forms, GHK-Cu, is the form most of the research concerns, and the copper is not incidental packaging. Copper is a cofactor for lysyl oxidase and superoxide dismutase among others, and much of the published interest in GHK-Cu concerns copper delivery and the downstream consequences of that.
The published work on GHK-Cu is unusually broad for a cosmetic peptide. It spans wound healing models, extracellular matrix turnover including collagen and glycosaminoglycan synthesis, antioxidant behaviour and, more recently, gene expression profiling reporting changes across large numbers of genes in cultured fibroblasts. That breadth is a strength and also a trap: a great deal of it is in vitro or in animal models, and the step from a cell culture readout to a meaningful effect in intact tissue is not automatic.
AHK-Cu substitutes alanine for glycine at the first position. It binds copper by the same histidine and lysine arrangement, and it is generally discussed in the context of hair follicle and dermal papilla research rather than the broader matrix literature that surrounds GHK. The evidence base is considerably smaller. Treating AHK-Cu as simply a variant of GHK-Cu, and importing GHK conclusions wholesale, is not supported.
Class two: matrix signal peptides
Matrixyl is the trade name most people know. The underlying compound is palmitoyl pentapeptide-4, a five residue sequence derived from a fragment of type I procollagen, with palmitic acid attached.
The mechanistic idea is different from the copper class and worth understanding on its own terms. When collagen in the extracellular matrix breaks down, it releases characteristic fragments. The proposal is that fibroblasts detect those fragments as a signal that matrix repair is required, and respond by increasing synthesis. A synthetic peptide matching such a fragment is therefore proposed to act as a feedback signal, telling the cell that damage has occurred in the absence of actual damage.
The palmitoyl group is a delivery modification rather than part of the signal. The peptide alone is water soluble and crosses lipid rich barriers poorly. The fatty acid tail makes the molecule amphiphilic and improves partitioning into membranes. When you see palmitoyl at the front of a cosmetic peptide name, it is describing how the molecule is intended to get where it is going, not what it does when it arrives.
Class three: neuropeptide analogues
SNAP-8 belongs to a different world again. It is an eight residue peptide, acetyl glutamyl heptapeptide-3, modelled on a segment of SNAP-25.
SNAP-25 is a component of the SNARE complex, the machinery that docks and fuses neurotransmitter containing vesicles with the presynaptic membrane at the neuromuscular junction. The proposed mechanism for SNAP-8 is competitive: a peptide resembling part of SNAP-25 may interfere with proper assembly of that complex, reducing the efficiency of vesicle fusion. This is why the class is sometimes described in the literature by analogy to botulinum mechanisms, though the two operate very differently. Botulinum toxin is an enzyme that cleaves SNARE proteins. A peptide analogue, if it acts as proposed, competes for assembly rather than destroying anything.
The important point for a researcher is categorical. This is a neurotransmission model. Nothing in the copper complex or matrix signal literature has any bearing on it, and vice versa.
Why the distinction matters when reading claims
Two practical consequences follow.
Evidence does not transfer between classes
A gene expression finding for GHK-Cu says nothing about SNAP-8. A penetration study on a palmitoylated pentapeptide says nothing about how an unmodified copper tripeptide behaves. Marketing copy routinely blends findings across all three, producing a composite claim that no single compound supports.
Formulation constraints differ
A copper complex is a metal coordination compound and its stability depends on pH and on what else is present that might compete for the copper. A palmitoylated peptide is a delivery optimised amphiphile with different solubility behaviour entirely. An acetylated octapeptide is different again. Handling and storage assumptions carried over from one class to another are not safe.
The dermatological range at Peptx
Peptx supplies GHK-Cu, AHK-Cu, GHK basic, Matrixyl, SNAP-8 and hyaluronic acid within the dermatological research category, alongside single vial formats of the copper peptides in the UK Express range.
We describe these compounds by class and by what the literature reports, without transferring findings between them. Identity and purity of what we supply are measured and published in the COA library exactly as the issuing laboratory reported them. All material is supplied strictly for laboratory research use.